NAYA Biosciences Inc.

0.39
-0.00 (-1.07%)
At close: Feb 11, 2025, 3:59 PM
0.38
-3.65%
After-hours Feb 11, 2025, 06:59 PM EST
undefined%
Bid 0.37
Market Cap 2.76M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -1.01
PE Ratio (ttm) -0.39
Forward PE n/a
Analyst Buy
Ask 0.4
Volume 280,173
Avg. Volume (20D) 157,475
Open 0.39
Previous Close 0.39
Day's Range 0.35 - 0.43
52-Week Range 0.35 - 3.50
Beta undefined

About NAYA

INVO Bioscience is a medical device company providing devices and products for infertility diagnosis. Its flagship product is INVOcell, a reproductive technology that allows fertilization and early embryo development to take place within the woman’s body....

Sector Healthcare
IPO Date Nov 2, 2020
Employees 30
Stock Exchange NASDAQ
Ticker Symbol NAYA

Analyst Forecast

According to 1 analyst ratings, the average rating for NAYA stock is "Buy." The 12-month stock price forecast is $2, which is an increase of 413.87% from the latest price.

Buy 100.00%
Hold 0.00%
Sell 0.00%
Stock Forecasts
4 weeks ago
-38.53%
NAYA Biosciences shares are trading lower after th... Unlock content with Pro Subscription
1 month ago
+9.74%
NAYA Biosciences shares are trading higher after the company announced the development of NY-500 novel AI-optimized PD X VEGF bifunctional antibody.
No News article available yet